Source:http://linkedlifedata.com/resource/pubmed/id/19768630
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-1-21
|
pubmed:abstractText |
The Plasmodium falciparum P0 ribosomal phosphoprotein (PfP0) was identified for the first time by screening a cDNA expression library of P. falciparum parasites with sera from malaria-immune individuals. Due to its localization on the surface of different parasite life-cycle stages (merozoites and gametocytes) and its recognition by invasion-blocking antibodies, PfP0 has been considered a potential malaria-vaccine component. In this study, 16 20-mer-long synthetic peptides spanning the entire PfP0 sequence were evaluated by means of receptor-ligand assays with human red blood cells (RBCs) in order to determine the role played by these peptides in the invasion process. Four RBC high-activity binding peptides (HABPs), located mostly toward the N-terminal region, were identified: HABP 33898 ((1)MAKLSKQQKKQMYIEKLSSL(20)), HABP 33900 ((41)ASVRKSLRGKATILMGKNTRY(60)), HABP 33901 ((61)IRTALKKNLQAVPQIEKLLPY (80)), and HABP 33906 ((161)LIKQGEKVTASSATLLRKFNY(180)). The binding pattern of HABPs 33898 and 33906 to enzyme-treated RBCs suggests receptors of protein nature for these two HABPs, one of which could correspond to a common 58-kDa RBC membrane protein, as indicated by results of cross-linking assays. Both HABPs exhibited high content of alpha-helical features and prevented P. falciparum merozoite invasion to RBCs in vitro by up to 91%. The invasion-blocking ability reported here for these PfP0 HABPs supports their inclusion in immunological studies with the aim of assessing their potential as candidates for a vaccine against P. falciparum malaria.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1432-1440
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-74
|
pubmed:dateRevised |
2011-7-8
|
pubmed:meshHeading |
pubmed-meshheading:19768630-Amino Acid Sequence,
pubmed-meshheading:19768630-Erythrocytes,
pubmed-meshheading:19768630-Humans,
pubmed-meshheading:19768630-Molecular Sequence Data,
pubmed-meshheading:19768630-Plasmodium falciparum,
pubmed-meshheading:19768630-Protein Binding,
pubmed-meshheading:19768630-Protozoan Proteins,
pubmed-meshheading:19768630-Ribosomal Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells.
|
pubmed:affiliation |
Fundación Instituto de Inmunología de Colombia FIDIC, Cra. 50 No 26-20, Bogotá, Colombia.
|
pubmed:publicationType |
Journal Article
|